Osteoarthritis

Effect of a combination of C. longa and B. serrata extracts on hand osteoarthritis. Results of a double-blind, randomized, placebo-controlled, multicenter trial

Osteoarthritis CartilagePublished Randomised controlled trial

Primary result · Pain VAS, mean decrease from baselineResult — go to the resultDifference between groups −8.5 mm 95% CI −16.4 to −0.6

Authors' conclusion

CBTIL relieves pain in patients with hand osteoarthritis.

Study context

Population
Patients with symptomatic hand OA meeting ACR criteria, BMI ≤ 35 Kg/m²
Participants
162 patients
Comparison
CBTIL two tablets per day vs placebo for 3 months
  • CBTILn = 83
  • Placebon = 79reference
Primary endpoint
Difference in pain change on VAS between baseline and month 3
Follow-up
Month 3
Methodological detailsdouble-blind, placebo-controlled, multicentre
  • Double-blind
  • Placebo-controlled
  • Multicentre

Primary result

Pain VAS, mean decrease from baseline

Difference between groups

−8.5 mm

95% CI −16.4 to −0.6

P = 0.03

Change by group

CBTIL

−24.7

mean · 95% CI −30.7–-18.7 · mm

Placebo

−16.2

mean · 95% CI −22.5–-9.9 · mm

CBTILvs Placebo
Difference between groups −8.5 mm (95% CI −16.4 to −0.6); P = 0.03

As reported in the abstract

Secondary outcomes

OutcomeDifference (mm) (95% CI)
Patient global assessment · 3 months−9.6 (−16.9 to −2.2)
OutcomeOR (95% CI)
Patients achieving acceptable symptom status (PASS) · 3 months1.9 (1.0–3.8)
OutcomeDifference (units) (95% CI)
SF-36 pain · 3 months7.1 (1.7–12.4)
SF-36 health change · 3 months6.7 (1.2–12.2)

Other secondary outcomes

Did not significantly differ between the two groups

Safety

Adverse events

No significant difference between the groups

Original publication

Effect of a combination of C. longa and B. serrata extracts on hand osteoarthritis. Results of a double-blind, randomized, placebo-controlled, multicenter trial. Osteoarthritis Cartilage. Published 17 June 2025. doi:10.1016/j.joca.2025.06.005

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.